Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Stuttgart - Delayed Quote • EUR Kezar Life Sciences Inc. (2KZ0.SG) Follow Compare 3.5000 -0.0800 (-2.23%) At close: April 16 at 9:35:11 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 2KZ0.SG 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 2KZ0.SG View More All News Press Releases SEC Filings Kezar Life Sciences Announces Positive Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis (AIH) and Reports Fourth Quarter and Year End 2024 Financial Results Kezar Life Sciences to Present Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis on March 25, 2025 Kezar Life Sciences to Present at Virtual KOL Event Hosted by William Blair on Zetomipzomib Clinical Development in Autoimmune Hepatitis and Provide a Safety Update from the PALIZADE Trial for Lupus Nephritis on February 27, 2025 Kezar Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update Related Tickers PBS0.F Precision BioSciences, Inc. 4.5000 +2.27% ASMB Assembly Biosciences, Inc. 10.01 +1.99% PSTX CMRX Chimerix, Inc. 8.55 0.00% CTMX CytomX Therapeutics, Inc. 0.6297 -0.29% DTIL Precision BioSciences, Inc. 5.01 -9.24% VIR Vir Biotechnology, Inc. 5.44 -3.29%